Provided by Tiger Fintech (Singapore) Pte. Ltd.

Babson Capital Corporate Investors

20.08
+0.16000.80%
Post-market: 20.080.00000.00%16:05 EDT
Volume:30.70K
Turnover:618.53K
Market Cap:409.72M
PE:11.51
High:20.75
Open:20.75
Low:19.97
Close:19.92
Loading ...

Keeping my 12-year-old safe from 'sus' online content: Why a smartwatch makes more sense than a smartphone

CNA
·
06 May

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback

GlobeNewswire
·
01 May

India's Wholesale Price Index Sustains Cooling in March

MT Newswires Live
·
15 Apr

Quest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease

PR Newswire
·
09 Apr

MCI Onehealth Technologies: Strategic Acquisitions and Revenue Growth Drive Buy Rating

TIPRANKS
·
03 Apr

Stifel Nicolaus Sticks to Its Buy Rating for MCI Onehealth Technologies, Inc. Class A (AIDX)

TIPRANKS
·
01 Apr

The European Commission refers lecanemab decision to Appeal Committee

PR Newswire
·
01 Apr

CLEAR, an Official TSA PreCheck® Enrollment Provider, Expands Enrollment and Renewal Options by Opening New Locations

GlobeNewswire
·
24 Mar

India's Wholesale Price Index Remains Moderate in February

MT Newswires Live
·
18 Mar

The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer's Disease

PR Newswire
·
28 Feb

The Committee for Medicinal Products for Human Use (CHMP) reaffirms positive opinion for Lecanemab in early Alzheimer's disease in the EU

PR Newswire
·
28 Feb

Barings Corporate Investors Q4 Dividend USD 0.1

THOMSON REUTERS
·
28 Feb

Barings Corporate Investors Reports Preliminary Fourth Quarter 2024 Results

Business Wire
·
28 Feb

Maxim Group Sticks to Its Buy Rating for MCI Onehealth Technologies, Inc. Class A (AIDX)

TIPRANKS
·
04 Feb

SAGE Rejects Biogen's Offer to Buy Remaining Stake, Stock Up

Zacks
·
29 Jan

FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US

PR Newswire
·
27 Jan

NFI’s MCI Secures Major Contract with Metrolinx

TIPRANKS
·
21 Jan

BRIEF-NFI Subsidiary MCI Awarded Five-Year Contract From Metrolinx

Reuters
·
21 Jan

Hosting sporting events in Singapore not just about 'economic receipts': SportSG chief

CNA
·
16 Jan

FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US

PR Newswire
·
14 Jan